Open original FDA record ↗Recall record
- FDA identifier
- Z-0211-2012
- Company in FDA record
- AGFA Corp.
- FDA classification date
- Nov 18, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Improper merging of IMPAX Cardiovascular Results Management (RM) reports causes the signed report to become unavailable.
Source facts
- Action
- AGFA Healthcare sent an "URGENT FIELD SAFETY NOTICE" letter dated May 27, 2011, via Fed Ex to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed not to carry out a merge post finalization of an RM reports. If it is necessary to modify a finalized report, AGFA recommends that they make the modification through one of the following actions: Amend the report through the RM interface, or Call AGFA Service to change the status of the report to "preliminary" and then proceed with the finalization of the report. AGFA issued an Acknowledgment, via FAX- Back that the information was received and understood to affected customers. For any questions customers were instructed to contact their AGFA Healthcare Service at 877-777-2432.
- Initiated
- 2011-06-06
- Root cause
- Software design
- Terminated
- 2013-07-02
- Distribution
- Worldwide Distribution - USA (nationwide) and Canada
- Recall number
- Z-0211-2012
- Recall status
- Terminated
- CDRH record ID
- 104617
- FDA classified
- 2011-11-18
- Recall event number
- 60154